Theranexus (France) Executives
| ALTHX Stock | EUR 1.09 0.02 1.87% |
Theranexus employs about 19 people. The company is managed by 6 executives with a total tenure of roughly 17 years, averaging almost 2.0 years of service per executive, having 3.17 employees per reported executive. Discussion of Theranexus' management performance can provide insight into the enterprise performance.
| Franck Mouthon Chairman Chairman of the Board, CEO |
Theranexus |
Theranexus Management Team Effectiveness
The company has return on total asset (ROA) of (0.2922) % which means that it has lost $0.2922 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7395) %, meaning that it generated substantial loss on money invested by shareholders. Theranexus' management efficiency ratios could be used to measure how well Theranexus manages its routine affairs as well as how well it operates its assets and liabilities.Theranexus Workforce Comparison
Theranexus SA is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 268. Theranexus holds roughly 19.0 in number of employees claiming about 7% of equities under Health Care industry.
Theranexus SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Theranexus SA Price Series Summation is a cross summation of Theranexus price series and its benchmark/peer.
Theranexus Notable Stakeholders
A Theranexus stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Theranexus often face trade-offs trying to please all of them. Theranexus' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Theranexus' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Franck Mouthon | Chairman of the Board, CEO | Profile | |
| Thierry Lambert | CFO Director | Profile | |
| Julien Veys | Chief Business Development Officer | Profile | |
| Francoise VincentLarrode | Director HR | Profile | |
| Marie Sebille | Chief Officer | Profile | |
| Mathieu Charvriat | Deputy Officer | Profile |
About Theranexus Management Performance
The success or failure of an entity such as Theranexus SA often depends on how effective the management is. Theranexus management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Theranexus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Theranexus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Theranexus socit anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company was founded in 2013 and is based in Lyon, France. THERANEXUS is traded on Paris Stock Exchange in France.
Theranexus Workforce Analysis
Traditionally, organizations such as Theranexus use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Theranexus within its industry.Theranexus Manpower Efficiency
Return on Theranexus Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 429K | |
| Net Loss Per Executive | 1.4M |
Additional Tools for Theranexus Stock Analysis
When running Theranexus' price analysis, check to measure Theranexus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theranexus is operating at the current time. Most of Theranexus' value examination focuses on studying past and present price action to predict the probability of Theranexus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theranexus' price. Additionally, you may evaluate how the addition of Theranexus to your portfolios can decrease your overall portfolio volatility.